Helixon Biotechnology (Suzhou) Co., Ltd
Helixon Biotechnology (Suzhou) Co., Ltd
Explore linked clinical trials.6 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I Study of HXN5003 in Healthy Participants and Patients With Moderate-to-Severe Atopic Dermatitis | Health Adult Subjects; Moderate-to-Severe Atopic Dermatitis | Not yet recruiting | Phase 1 | 2026-09-03 | NCT07801612 | |
| Study of HXN6005 in Healthy Participants and Patients With Moderate-to-Severe Atopic Dermatitis | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder | Not yet recruiting | Phase 1 / Phase 2 | 2026-08-24 | NCT07782476 | |
| A Study to Evaluate the Safety, Tolerability, PK and Preliminary Efficacy of HX15001 Combined With Etrasimod in Moderate-severe Ulcerative Colitis | Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Not yet recruiting | Phase 1 | 2026-08-17 | NCT07768254 | |
| A Dose Escalation Phase 1 Study of HXN5003 in Healthy Participants | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder | Not yet recruiting | Phase 1 | 2026-04-24 | NCT07549750 | |
| Phase I Study of HXN6005 in Adult Healthy Participants | Healthy Volunteers (HV) | Recruiting | Phase 1 | 2026-04-24 | NCT07449741 | |
| Study of HX15001 in Adult Healthy Volunteers. | Healthy Volunteers | Recruiting | Phase 1 | 2025-08-24 | NCT06999720 |